These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36657800)

  • 41. A subset of patients with eosinophilic esophagitis demonstrate delayed gastric emptying.
    Khosh-Hemmat E; Babbel J; Chaiboonma K; Dohil R; Aceves SS
    J Allergy Clin Immunol Pract; 2022 Oct; 10(10):2764-2767.e1. PubMed ID: 35779782
    [No Abstract]   [Full Text] [Related]  

  • 42. GATA-3 and T-bet as diagnostic markers of non-esophageal eosinophilic gastrointestinal disease.
    Neely JL; Reimers A; Taylor S; Garg S; Masuda MY; Schroeder S; Wright BL; Doyle AD
    Allergy; 2022 Mar; 77(3):1042-1044. PubMed ID: 34735725
    [No Abstract]   [Full Text] [Related]  

  • 43. Eosinophilic Esophagitis: Incidence, Diagnosis, Management, and Future Directions.
    Fernandez-Becker NQ
    Gastroenterol Clin North Am; 2021 Dec; 50(4):825-841. PubMed ID: 34717873
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Eosinophilic oesophagitis and type 2 inflammation multimorbidity: an opportunity for biologic treatment.
    Franceschini L; Farsi A
    Lancet Gastroenterol Hepatol; 2022 Sep; 7(9):787-788. PubMed ID: 35932768
    [No Abstract]   [Full Text] [Related]  

  • 45. Low Prevalence of Extraesophageal Gastrointestinal Pathology in Patients with Eosinophilic Esophagitis.
    Hiramoto B; Zalewski A; Gregory D; Yang GY; Ho N; Gonsalves N; Hirano I
    Dig Dis Sci; 2022 Jul; 67(7):3080-3088. PubMed ID: 34195891
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Adults with eosinophilic esophagitis are poorly adherent to treatment plans: Data from a community practice.
    Holbreich M; Dellon ES
    Ann Allergy Asthma Immunol; 2023 Oct; 131(4):523-524.e4. PubMed ID: 37433384
    [No Abstract]   [Full Text] [Related]  

  • 47. Biologics in the Treatment of Eosinophilic Esophagitis: Ready for Use?
    Snyder DL; Dellon ES
    Clin Gastroenterol Hepatol; 2023 Dec; 21(13):3230-3233. PubMed ID: 37715779
    [No Abstract]   [Full Text] [Related]  

  • 48. Oral peanut immunotherapy acutely unmasking eosinophilic esophagitis with an esophageal stricture.
    Avinashi V; Al Yarubi Z; Soller L; Lam G; Chan ES
    Ann Allergy Asthma Immunol; 2021 Dec; 127(6):691-692. PubMed ID: 34517129
    [No Abstract]   [Full Text] [Related]  

  • 49. The importance of studying genetic ancestry in eosinophilic esophagitis.
    Marker KM; Mathias RA; Gignoux CR
    J Allergy Clin Immunol; 2023 May; 151(5):1244-1245. PubMed ID: 36963618
    [No Abstract]   [Full Text] [Related]  

  • 50. The incidence of eosinophilic oesophagitis in 2007-2017 among children in North Denmark Region is lower than expected.
    Hollænder M; Terkelsen JH; Kramme F; Bredal K; Kragholm K; Dalby K; Hagstrøm S; Melgaard D; Krarup AL
    BMC Pediatr; 2022 Apr; 22(1):183. PubMed ID: 35387630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphocytic oesophagitis: diagnosis and management.
    Hussein M; Mitchison M; Sweis R
    Clin Med (Lond); 2023 Nov; 23(6):540-544. PubMed ID: 38065611
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Disease associations in eosinophilic oesophagitis and oesophageal eosinophilia.
    Lucendo AJ
    Best Pract Res Clin Gastroenterol; 2015 Oct; 29(5):759-769. PubMed ID: 26552775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Eosinophilic esophagitis despite isolated IgG4 deficiency: The still unsolved conundrum of pathogenesis.
    Franceschini L; Biviano I; Malaspina L; Macchiarelli R; Farsi A
    Ann Allergy Asthma Immunol; 2023 Oct; 131(4):525-526. PubMed ID: 37453574
    [No Abstract]   [Full Text] [Related]  

  • 54. The LIGHT switch: mechanisms of fibroblast pathology in eosinophilic esophagitis.
    Chua ZMX; Fletcher AL
    Mucosal Immunol; 2022 Feb; 15(2):195-197. PubMed ID: 35197559
    [No Abstract]   [Full Text] [Related]  

  • 55. Sex Impacts Disease Activity But Not Symptoms or Quality of Life in Adults With Eosinophilic Esophagitis.
    Schreiner P; Safroneeva E; Rossel JB; Limacher A; Saner C; Greuter T; Schoepfer A; Straumann A; Biedermann L
    Clin Gastroenterol Hepatol; 2022 Aug; 20(8):1729-1738.e1. PubMed ID: 34798333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Eosinophilic Gastrointestinal Disorders: A new Path.
    Arva N; Genta RM; Pletneva M; Walker MM; Yang GY; Collins MH
    Pediatr Dev Pathol; 2022; 25(5):568-569. PubMed ID: 35535658
    [No Abstract]   [Full Text] [Related]  

  • 57. The importance of using core outcome measures during therapeutic studies of eosinophilic esophagitis.
    Hill DA
    J Allergy Clin Immunol; 2022 Feb; 149(2):541-542. PubMed ID: 34599977
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical profile and characteristics of eosinophilic esophagitis patients presenting with refractory gastroesophageal reflux disease in Makassar, Indonesia.
    Kaurrany MR; Akil MA; Punagi AQ; Parewangi AML
    Pan Afr Med J; 2022; 41():93. PubMed ID: 35465366
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Diagnosis and Treatment of Eosinophilic Esophagitis].
    Kim SJ; Choi CW; Hwang CS
    Korean J Gastroenterol; 2022 Mar; 79(3):99-108. PubMed ID: 35342167
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Eosinophilic esophagitis: a rising disease.
    DE Bortoli N; Savarino E
    Minerva Gastroenterol (Torino); 2022 Mar; 68(1):7-8. PubMed ID: 33222433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.